MoonLake Immunotherapeutics (NASDAQ: MLTX) Email Format
Biotechnology ResearchSwitzerland51-200 Employees
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.